Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

This early-phase trial tested a combination of two drugs—TQB2928 (an antibody that helps the immune system attack cancer cells) and anlotinib (a drug that cuts off tumor blood supply)—in 20 people with advanced osteosarcoma or other solid tumors that had stopped responding to sta…

This study tested a new pill called TQB3909 in 19 adults with mantle cell lymphoma that returned or didn't respond to other treatments. The main goal was to find a safe dose and check for side effects. The trial was ended early, so results are limited.

This early-stage study tested the safety of a new drug called AP026 in healthy adults. The trial was stopped early after enrolling only 14 people. Its main goal was to check for side effects, not to treat diabetes. No treatment benefit was expected for participants.